ABCB11 and cystic fibrosis: The field of personalized pharmacotherapy research is very active in diseases involving proteins of the family of ABC transporters, including hepatocellular genetic cholestasis, such as PFIC2, as well as CF for which very efficient compounds have been identified and are now used in routine clinical practice [9,10,11,12].